Kai Kupferschmidt on Nostr: FDA has rejected approval of MDMA-assisted psychotherapy to treat PTSD for now. ...

FDA has rejected approval of MDMA-assisted psychotherapy to treat PTSD for now. According to Lykos Therapeutics the agency “has requested that Lykos conduct an additional Phase 3 trial to further study the safety and efficacy of midomafetamine”.

https://news.lykospbc.com/2024-08-09-Lykos-Therapeutics-Announces-Complete-Response-Letter-for-Midomafetamine-Capsules-for-PTSD